Publicación:
Association of salivary inflammatory biomarkers with primary Sjögren's syndrome

Página de artículo simple
dc.contributor.author Moreno-Quispe L.A. es_PE
dc.contributor.author Serrano J. es_PE
dc.contributor.author Virto L. es_PE
dc.contributor.author Sanz M. es_PE
dc.contributor.author Ramírez L. es_PE
dc.contributor.author Fernández-Castro M. es_PE
dc.contributor.author Hernández G. es_PE
dc.contributor.author López-Pintor R.M. es_PE
dc.date.accessioned 2024-05-30T23:13:38Z
dc.date.available 2024-05-30T23:13:38Z
dc.date.issued 2020
dc.description.abstract Background: Primary Sjogren's syndrome (pSS) is an autoimmune disease that leads to salivary and lacrimal gland dysfunction. The adaptive immune response associated with T helper-2 lymphocytes appears to be altered in these patients. Therefore, the objective of this study was to determine the salivary levels of interleukin (IL)-6, IL-5, and IL-4 in patients with pSS when compared to a healthy control (HC) group. The secondary objectives were to study whether ILs levels in pSS patients were associated with salivary flow, patient-reported outcomes (PROMs) for xerostomia and oral health quality of life (Oral Health Impact Profile-14 [OHIP-14]), pSS classification criteria and presence of extraglandular manifestations. Methods: A case-control study was conducted in 36 patients with pSS and 35 HCs. Cytokine levels were measured using high-sensitivity multiplex map human immunoassays. Unstimulated and stimulated whole saliva were collected and patients filled out questionnaires. The Mann-Whitney U test, chi-squared test, and Spearman correlation test were used. Results: Interleukin-6 was significantly higher in pSS patients than in HCs (P =.0001). IL-6 was significantly higher in pSS patients with a positive salivary gland biopsy (P =.04), whole stimulated saliva hyposalivation (P =.02), and presence of musculoskeletal disorders (P =.03). There was a non-significant positive correlation between IL-6 levels and PROMs for xerostomia (r =.31; P =.06) and OHIP-14 (r =.07; P =.68) in pSS patients. Levels of IL-4 and IL-5 were not detected in both pSS and HCs patients. Conclusions: Salivary IL-6 levels are significantly associated with pSS patients, and therefore, it is hypothesized that this biomarker may be useful in the diagnosis and follow-up of this disease. © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
dc.description.sponsorship Fondo Nacional de Desarrollo Científico y Tecnológico - Fondecyt
dc.identifier.doi https://doi.org/10.1111/jop.13070
dc.identifier.scopus 2-s2.0-85087318235
dc.identifier.uri https://hdl.handle.net/20.500.12390/2478
dc.language.iso eng
dc.publisher Blackwell Publishing Ltd
dc.relation.ispartof Journal of Oral Pathology and Medicine
dc.rights info:eu-repo/semantics/openAccess
dc.subject Visual Analog Scale for xerostomia
dc.subject Oral Health Impact Profile-14 es_PE
dc.subject primary Sjögrens syndrome es_PE
dc.subject Salivary biomarkers es_PE
dc.subject salivary interleukins es_PE
dc.subject.ocde http://purl.org/pe-repo/ocde/ford#3.03.08
dc.title Association of salivary inflammatory biomarkers with primary Sjögren's syndrome
dc.type info:eu-repo/semantics/article
dspace.entity.type Publication
oairecerif.author.affiliation #PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation #PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation #PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation #PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation #PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation #PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation #PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation #PLACEHOLDER_PARENT_METADATA_VALUE#
Archivos
Colecciones
1.1 Eventos institucionales
 2.1 Estudios de doctorado y postdoctorado